Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotatercept Pharmacodynamics in Solid Tumors
NCT01190644Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jun 2010
- Primary completion
- Sep 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of sotatercept in anemia, sponsored by Merck & Co.. Started Jun 2010; status: terminated.
02
Drugs
sotatercept
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01190644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190644.